FVCB:NASDAQFVCBankcorp, Inc. Analysis
Data as of 2026-07-19 - not real-time
$17.82
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
FVCBankcorp is trading in the mid‑$teens with a bullish technical set‑up: the 20‑day SMA (≈$17.4) sits above the 50‑day SMA (≈$16.5) and both are above the 200‑day SMA (≈$14.7), confirming an uptrend. The RSI is at 61, indicating momentum without overbought pressure, while the MACD line has crossed above its signal line, generating a bullish histogram. Price is holding just above the identified support around $16.42 and below the resistance near $18.36, suggesting limited downside and a modest upside target. Fundamentally, the stock trades at a forward PE of 11.2 versus an industry average of 17.8, and the DCF model values the company at roughly $35, implying a substantial undervaluation gap. Revenue growth of 16‑17% and an operating margin near 47% underscore strong earnings power, while a low payout ratio (≈14%) and a newly declared $0.07 dividend point to sustainable income. The balance sheet is solid with ample cash, modest debt, and a beta of 0.5, indicating lower market sensitivity. Overall, the combination of bullish technicals, attractive valuation, and steady dividend makes FVCB a compelling candidate for investors seeking growth‑oriented value in the regional banking sector.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish technical alignment (SMA hierarchy, MACD crossover)
- Support level intact and volume trend still supportive
- Recent dividend declaration adds immediate yield
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Valuation gap suggests modest upside but price near resistance
- Sustained earnings growth and strong operating margins
- Regional bank sector exposure to credit cycles
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF fair value indicates significant upside over current price
- Low beta and solid balance sheet reduce systematic risk
- Stable dividend with low payout ratio supports total return
Key Metrics & Analysis
Financial Health
Revenue Growth16.70%
Profit Margin34.03%
P/E Ratio13.9
ROE9.26%
ROA1.02%
P/B Ratio1.2
Op. Cash Flow$26.1M
Industry P/E17.8
Technical Analysis
TrendBullish
RSI61.1
Support$16.42
Resistance$18.36
MA 20$17.42
MA 50$16.53
MA 200$14.74
MACDBullish
VolumeDecreasing
Fear & Greed Index87.91
Valuation
Fair Value$35.25
Target Price$18.38
Upside/Downside3.11%
GradeUndervalued
TypeGrowth
Dividend Yield1.57%
Risk Assessment
Beta0.50
Volatility21.62%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.